Antiviral interactions of an HCV polymerase inhibitor with an HCV protease inhibitor or interferon in vitro-Reference-Cited by-同舟云学术

Antiviral interactions of an HCV polymerase inhibitor with an HCV protease inhibitor or interferon in vitro

Published:2007-01 Issue:1 Volume:73 Page:78-83
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Koev Gennadiy,Dekhtyar Tatyana,Han Lixin,Yan Ping,Ng Teresa I.,Lin C. Thomas,Mo Hongmei,Molla Akhteruzzaman

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference41 articles.

1. Final phase I/II trial results for NM283, a new polymerase inhibitor for hepatitis C: antiviral efficacy and tolerance in patients with HCV-1 infection, including previous interferon failures;Afdhal;Hepatology,2004

2. Combination therapy with interferon alfa and ribavirin as retreatment of interferon relapse in chronic hepatitis C;Davis;Semin. Liver Dis.,1999

3. Combination treatment with interferon and ribavirin for chronic hepatitis C;Davis;Clin. Liver Dis.,1999

4. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group;Davis;N. Engl. J. Med.,1998

5. Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase;De Francesco;Antivir. Res.,2003

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring theophylline-1,2,4-triazole tethered N-phenylacetamide derivatives as antimicrobial agents: unraveling mechanisms via structure-activity relationship, in vitro validation, and in silico insights;Frontiers in Chemistry;2024-04-05

2. Coronavirus enzyme inhibitors-experimentally proven natural compounds from plants;Journal of Microbiology;2022-01-28

3. Identification of drug resistance and immune-driven variations in hepatitis C virus (HCV) NS3/4A, NS5A and NS5B regions reveals a new approach toward personalized medicine;Antiviral Research;2017-01

4. Hepatitis C Virus Polymerase as a Target for Antiviral Drug Intervention: Non-Nucleoside Inhibitors;Antiviral Research;2014-04-30

5. Clinical Aspects of Hepatitis C Virus Infection;Antiviral Research;2014-04-30